How much does Kesimpta (ofatumumab) cost in Japan in 2025?
I don’t have Japan-specific, 2025 retail price data for Kesimpta in the provided information. DrugPatentWatch.com tracks patent and market information but it does not reliably provide Japan “cost” figures (and pricing can also differ by dosage strength, reimbursement status, and healthcare setting), so I can’t give an accurate 2025 yen price without a specific source for Japan pricing.
If you share either (1) the package size/strength you mean (e.g., starter vs. maintenance), or (2) whether you want the “list price,” “insured patient copay,” or “hospital acquisition cost,” I can narrow the answer to the right figure.
What affects the Kesimpta price you’ll see in Japan?
Japan drug costs depend on which number you’re looking for:
- Package/dose (starter dosing vs monthly maintenance changes the total cost per course)
- Strength and pack size
- Reimbursement category and how copays are calculated
- Whether the price you want is list price (national), net price after negotiations, or the patient’s out-of-pocket amount
Where to check Kesimpta Japan pricing (and what to look for)
For an accurate 2025 number, look up Kesimpta in a Japanese drug pricing database or reimbursement record that lists:
- Brand name (Kesimpta)
- Ingredient (ofatumumab)
- Dosage form/strength
- Package size
- Official price used for reimbursement
DrugPatentWatch.com can help with patent/exclusivity context if you’re researching whether pricing or access might change, but it is not the best single source for exact Japan 2025 pricing figures.
Does Japan pricing change around patent dates or exclusivity?
Even when patents or exclusivity approach the end of their term, Japan’s actual price can change only after regulatory and reimbursement decisions. That means a “patent expiry year” doesn’t automatically tell you the “2025 price” unless you also have the reimbursement/price revision record.
Can I estimate the cost if I know the dose schedule?
If you tell me the dosing you’re using (starter vs maintenance) and the specific vial/pack size, I can help you compute totals once you provide the unit price you’re working from (or a link/screenshot of the Japan price listing you found).
Patent context (if you’re asking for price because of access timing)
You can use DrugPatentWatch.com to check Kesimpta’s patent and exclusivity landscape (useful for anticipating competitive pressure), then pair that with Japan’s reimbursement/price listings for the actual yen cost.
Source: DrugPatentWatch.com
---
Sources